(Q57826041)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Peter Celec

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Katarína Sebekova

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

5

Július Hodosy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Ciro Esposito

7

0 references

August Heidland

11

object named as

August Heidland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Luigi Villa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Kristína Klenovicsová

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Stefan Schäfer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Barbara Albrecht-Küpper

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Tammo Ostendorf

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Ina V Martin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

3 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

1182-1197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2011.254

9 February 2020

exact match

0 references

cites work

Treatment targets in renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

PPAR-alpha ligands inhibit H2O2-mediated activation of transforming growth factor-beta1 in human mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Peroxisome proliferator-activated receptor-alpha contributes to the resolution of inflammation after renal ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

PPARalpha protects proximal tubular cells from acute fatty acid toxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Peroxisome proliferator-activated receptor alpha protects against glomerulonephritis induced by long-term exposure to the plasticizer di-(2-ethylhexyl)phthalate.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Identification of functions of peroxisome proliferator-activated receptor alpha in proximal tubules.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

The peroxisome proliferator-activated receptor alpha activator fenofibrate inhibits endothelin-1-induced cardiac fibroblast proliferation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Obstructive nephropathy: towards biomarker discovery and gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Obstructive nephropathy and renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Complement C5 mediates experimental tubulointerstitial fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Niacin improves renal lipid metabolism and slows progression in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Peroxisome proliferator-activated receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Fenofibrate in the treatment of dyslipidemia: a review of the data as they relate to the new suprabioavailable tablet formulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.254

7 January 2021

Identifiers

DOI

10.1038/KI.2011.254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21814170%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference